ICON EBITDA 2010-2024 | ICLR

ICON annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • ICON EBITDA for the quarter ending September 30, 2024 was $0.391B, a 6.72% decline year-over-year.
  • ICON EBITDA for the twelve months ending September 30, 2024 was $1.612B, a 8.8% increase year-over-year.
  • ICON 2023 annual EBITDA was $1.542B, a 13% increase from 2022.
  • ICON 2022 annual EBITDA was $1.365B, a 96.79% increase from 2021.
  • ICON 2021 annual EBITDA was $0.694B, a 51.55% increase from 2020.
ICON Annual EBITDA
(Millions of US $)
2023 $1,542
2022 $1,365
2021 $694
2020 $458
2019 $525
2018 $439
2017 $400
2016 $371
2015 $339
2014 $255
2013 $167
2012 $111
2011 $78
2010 $126
2009 $149
ICON Quarterly EBITDA
(Millions of US $)
2024-09-30 $391
2024-06-30 $379
2024-03-31 $435
2023-12-31 $406
2023-09-30 $419
2023-06-30 $355
2023-03-31 $362
2022-12-31 $346
2022-09-30 $386
2022-06-30 $322
2022-03-31 $312
2021-12-31 $284
2021-09-30 $146
2021-06-30 $128
2021-03-31 $136
2020-12-31 $137
2020-09-30 $111
2020-06-30 $87
2020-03-31 $123
2019-12-31 $139
2019-09-30 $133
2019-06-30 $129
2019-03-31 $125
2018-12-31 $117
2018-09-30 $115
2018-06-30 $99
2018-03-31 $109
2017-12-31 $106
2017-09-30 $101
2017-06-30 $92
2017-03-31 $100
2016-12-31 $100
2016-09-30 $92
2016-06-30 $88
2016-03-31 $91
2015-12-31 $91
2015-09-30 $86
2015-06-30 $82
2015-03-31 $81
2014-12-31 $66
2014-09-30 $73
2014-06-30 $61
2014-03-31 $54
2013-12-31 $41
2013-09-30 $45
2013-06-30 $42
2013-03-31 $141
2012-12-31 $29
2012-09-30 $31
2012-06-30 $28
2012-03-31 $113
2011-12-31 $17
2011-09-30 $11
2011-06-30 $25
2011-03-31 $101
2010-12-31 $121
2010-09-30 $26
2010-06-30 $34
2010-03-31 $36
2009-12-31 $39
2009-09-30 $39
2009-06-30 $37
2009-03-31 $34
Sector Industry Market Cap Revenue
Medical Medical Services $16.136B $8.120B
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00